Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares OutstandingShares Repurchased
Ratios

Genmab A (GNMSF) Receivables Refunds (2024 - 2025)

Historic Receivables Refunds for Genmab A (GNMSF) over the last 2 years, with Q4 2025 value amounting to $40.0 million.

  • Genmab A's Receivables Refunds rose 18571.43% to $40.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $40.0 million, marking a year-over-year increase of 18571.43%. This contributed to the annual value of $40.0 million for FY2025, which is 18571.43% up from last year.
  • Per Genmab A's latest filing, its Receivables Refunds stood at $40.0 million for Q4 2025, which was up 18571.43% from $14.0 million recorded in Q4 2024.
  • Genmab A's Receivables Refunds' 5-year high stood at $40.0 million during Q4 2025, with a 5-year trough of $14.0 million in Q4 2024.